Compare GHC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHC | ICUI |
|---|---|---|
| Founded | 1877 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.9B |
| IPO Year | 1994 | 1995 |
| Metric | GHC | ICUI |
|---|---|---|
| Price | $1,069.78 | $151.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $182.25 |
| AVG Volume (30 Days) | 13.6K | ★ 270.3K |
| Earning Date | 05-28-2026 | 05-22-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | ★ 66.47 | 0.03 |
| Revenue | ★ $2,932,099,000.00 | $2,231,262,000.00 |
| Revenue This Year | $10.54 | N/A |
| Revenue Next Year | $4.02 | $4.10 |
| P/E Ratio | ★ $25.18 | $5,170.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $875.60 | $107.02 |
| 52 Week High | $1,224.76 | $160.29 |
| Indicator | GHC | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 41.23 | 51.03 |
| Support Level | $1,060.95 | $142.11 |
| Resistance Level | $1,115.27 | $151.64 |
| Average True Range (ATR) | 38.94 | 6.63 |
| MACD | -5.91 | 0.29 |
| Stochastic Oscillator | 17.40 | 56.37 |
Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.